Urine creatine metabolite panel as a screening test in neurodevelopmental disorders
Open Access
- 2 December 2020
- journal article
- research article
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 15 (1) , 1-10
Abstract
Background: Cerebral creatine deficiency disorders (CCDD) are inherited metabolic disorders of creatine synthesis and transport. Urine creatine metabolite panel is helpful to identify these disorders. Methods: We reviewed electronic patient charts for all patients that underwent urine creatine metabolite panel testing in the metabolic laboratory at our institution. Results: There were 498 tests conducted on 413 patients. Clinical, molecular genetics and neuroimaging features were available in 318 patients. Two new patients were diagnosed with creatine transporter deficiency: one female and one male, both had markedly elevated urine creatine. Urine creatine metabolite panel was also used as a monitoring test in our metabolic laboratory. Diagnostic yield of urine creatine metabolite panel was 0.67% (2/297). There were six known patients with creatine transporter deficiency. The prevalence of creatine transporter deficiency was 2.64% in our study in patients with neurodevelopmental disorders who underwent screening or monitoring of CCDS at our institution. Conclusion: Even though the diagnostic yield of urine creatine metabolite panel is low, it can successfully detect CCDD patients, despite many neurodevelopmental disorders are not a result of CCDD. To the best of our knowledge, this study is the first Canadian study to report diagnostic yield of urine creatine metabolite panel for CCDD from a single center.Keywords
Funding Information
- Hospital for Sick Children
This publication has 11 references indexed in Scilit:
- Clinical Application of Targeted Next-Generation Sequencing Panels and Whole Exome Sequencing in Childhood EpilepsyNeuroscience, 2019
- Treatment outcome of twenty-two patients with guanidinoacetate methyltransferase deficiency: An international retrospective cohort studyEuropean Journal of Paediatric Neurology, 2018
- Treatment outcome of creatine transporter deficiency: international retrospective cohort studyMetabolic Brain Disease, 2018
- The role of dietary creatineAmino Acids, 2016
- Elevation of guanidinoacetate in newborn dried blood spots and impact of early treatment in GAMT deficiencyMolecular Genetics and Metabolism, 2013
- Understanding pyrroline‐5‐carboxylate synthetase deficiency: clinical, molecular, functional, and expression studies, structure‐based analysis, and novel therapy with arginineJournal of Inherited Metabolic Disease, 2011
- Simultaneous determination of guanidinoacetate, creatine and creatinine in urine and plasma by un-derivatized liquid chromatography-tandem mass spectrometryAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2008
- High cerebral guanidinoacetate and variable creatine concentrations in argininosuccinate synthetase and lyase deficiency: Implications for treatment?Molecular Genetics and Metabolism, 2006
- Presymptomatic treatment of neonatal guanidinoacetate methyltransferase deficiencyNeurology, 2006
- Reduced brain creatine in gyrate atrophy of the choroid and retina with hyperornithinemiaNeurology, 1999